GoHealth (NASDAQ: GOCO – get ranked) Stock market researchers Credit Suisse Group set a price target of $7.00 in a research report released to clients and investors on Thursday, according to Stock Target Advisor. Credit Suisse Group’s target price suggests a potential decline of 22.48% from the company’s previous close.
GoHealth trades up 2.0%
NASDAQ GOCO traded up $0.18 on Thursday to hit $9.03. 131,017 shares of the company were exchanged with an average volume of 135,818. The company has a debt to equity ratio of 1.40, a current ratio of 1.83 and a quick ratio of 1.83. GoHealth has a twelve-month low of $4.93 and a twelve-month high of $63.60. The firm has a market capitalization of $198.30 million, a P/E of -0.29, and a beta of 1.44. The company’s 50-day moving average price is $1.03 and the 200-day moving average price is $0.75.
Insider activity at GoHealth
In other news, on Monday, Nov. 21, Blizzard Holdings’ major shareholder CLP Cb purchased 61,334 shares. The shares were purchased at an average price of $7.92 per share for a total transaction value of $485,765.28. Following the transaction, the insider now owns 3,428,554 shares of the company, worth approximately $27,154,147.68. The acquisition was disclosed in documentation for the SEC, which is available on the SEC website. In other GoHealth news, on Monday, November 21, Blizzard Holdings major shareholder CLP Cb purchased 61,334 shares of the company. The shares were purchased at an average price of $7.92 per share for a total transaction value of $485,765.28. Following the transaction, the insider now owns 3,428,554 shares of the company, worth approximately $27,154,147.68. The purchase was disclosed in a document filed with the SEC, which can be accessed at this hyperlink. In addition, the main shareholder of Cayman Gp Ltd. Ccp III bought 3,000,000 shares of the company in a deal dated Tuesday, November 15th. The shares were purchased at an average price of $0.39 per share for a total transaction value of $1,170,000.00. After the acquisition, the insider now directly owns 43,682,961 shares of the company worth $17,036,354.79. Disclosure information about this purchase can be found here. In the past 90 days, insiders have bought 5,779,232 shares of the company worth $3,177,788. 6.70% of the shares are held by corporate insiders.
GoHealth Institutional Trading
Several institutional investors have recently bought and sold shares in GOCO. First Trust Advisors LP increased its stake in GoHealth by 164.4% during the 1st quarter. First Trust Advisors LP now owns 5,139,765 shares of the company worth $6,065,000 after acquiring an additional 3,195,549 shares in the most recent quarter. Black Rock Inc. increased its stake in GoHealth by 18.4% during the 1st quarter. Black Rock Inc. now owns 3,276,082 shares of the company worth $3,865,000 after purchasing an additional 509,565 shares during the last quarter. Renaissance Technologies LLC acquired a new position in GoHealth shares during the 1st quarter for $2,911,000. The Healthcare of Ontario Pension Plan Trust Fund increased its stake in GoHealth by 42.1% in the 2nd quarter. The Healthcare of Ontario Pension Plan Trust Fund now owns 1,544,595 shares of the company worth $924,000 after acquiring an additional 457,961 shares in the most recent quarter. Finally, State Street Corp increased its stake in GoHealth by 22.1% in the 1st quarter. State Street Corp now owns 1,100,601 shares of the company worth $1,299,000 after purchasing an additional 199,524 shares during the most recent quarter. Institutional investors and hedge funds own 20.28% of the company’s shares.
GoHealth Company Profile
GoHealth, Inc operates as a health insurance marketplace and Medicare digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that uses insurance behavior data machine learning algorithms to streamline the process of helping people find a health plan for their specific needs.
This instant news alert was created using MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reporting. This story has been reviewed by MarketBeat before publishing. Please send any questions or comments about this story to [email protected]
Before you think about GoHealth, you need to hear this.
MarketBeat tracks Wall Street’s most popular and effective analysts daily and the stocks they recommend to their clients. MarketBeat identified five stocks that top analysts are quietly whispering to their customers to buy now before the wider market takes notice… and GoHealth was not on the list.
While GoHealth is currently rated Hold by analysts, the top-rated analysts believe these five stocks are best buys.
View five promotions here